Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antihypertensive Treatment”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Large-scale testing (Phase 3)Study completedNCT01271985
What this trial is testing

Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

Who this might be right for
Cardiovascular Diseases
Tehran University of Medical Sciences 8,410
Not applicableStudy completedNCT05630521
What this trial is testing

Testing Feasibility of Medication Adherence Problem Solving for Hypertension

Who this might be right for
HypertensionAdherence, Medication
Rush University Medical Center 40
Not applicableStudy completedNCT02385721
What this trial is testing

Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan)

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 601
Post-approval studies (Phase 4)Study completedNCT00931710
What this trial is testing

Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic Hypertension

Who this might be right for
Stage 2 Systolic Hypertension
Novartis 488
Not applicableUnknownNCT04791046
What this trial is testing

Antihypertensive Therapy in Patients With Comorbidities

Who this might be right for
Adherence to Personalized EBM Antihypertensive Drug Prescriptions for Patients With Hypertension and Comorbidities in Everyday Clinical Practice
Center of Personalized Medicine, Pirogova 100,000
Not applicableNot Yet RecruitingNCT05406336
What this trial is testing

Machine Learning to Reduce Hypertension Treatment Clinical Inertia

Who this might be right for
Hypertension
Temple University 50
Testing effectiveness (Phase 2)Study completedNCT00097955
What this trial is testing

Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

Who this might be right for
Diabetic Nephropathy
Novartis Pharmaceuticals 496
Post-approval studies (Phase 4)WithdrawnNCT01042574
What this trial is testing

The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive Therapy

Who this might be right for
HypertensionIntracranial HemorrhageSubarachnoid Hemorrhage
Methodist Healthcare
Not applicableLooking for participantsNCT06402968
What this trial is testing

Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage

Who this might be right for
Intracerebral HemorrhageStrokeHypertension
Zeenat Qureshi Stroke Institute 1,000
Not applicableStudy completedNCT03292900
What this trial is testing

Association Between Genetic Algorithm to Predict Hypertension Therapy and Response to Treatment

Who this might be right for
Hypertension
Geneticure, LLC 758
Not applicableStudy completedNCT01108796
What this trial is testing

Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan

Who this might be right for
Hypertension
Boehringer Ingelheim 1,856
Post-approval studies (Phase 4)Study completedNCT01091753
What this trial is testing

Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers

Who this might be right for
Hypertension
Yonsei University 28
Large-scale testing (Phase 3)Study completedNCT02177422
What this trial is testing

Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

Who this might be right for
Hypertension
Boehringer Ingelheim 489
Testing effectiveness (Phase 2)Study completedNCT02822222
What this trial is testing

Safety Study of RMJH-111b to Treat Essential Hypertension

Who this might be right for
Essential Hypertension
RMJ Holdings, LLC 22
Not applicableUnknownNCT02060981
What this trial is testing

Evaluation of a Decision Support Tool

Who this might be right for
Medication AdherenceHypertensionDecision Making, Shared+1 more
Brigham and Women's Hospital 140
Testing effectiveness (Phase 2)Study completedNCT00922441
What this trial is testing

A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 92
Post-approval studies (Phase 4)Not Yet RecruitingNCT05169021
What this trial is testing

Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD

Who this might be right for
Cerebral Small Vessel DiseasesStroke
Beijing Tiantan Hospital 15,000
Testing effectiveness (Phase 2)Study completedNCT00520247
What this trial is testing

Effect of Enalapril Plus Folic Acid on Blood Pressure and Glycometabolism

Who this might be right for
Plasma Total Homocysteine LevelBlood Pressure
Anhui Medical University 443
Large-scale testing (Phase 3)WithdrawnNCT03585595
What this trial is testing

Intensive Blood Pressure Intervention in Stroke (IBIS) Trial

Who this might be right for
Ischemic Stroke
Tulane University
Early research (Phase 1)Ended earlyNCT01403922
What this trial is testing

To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic Hypertension

Who this might be right for
Chronic Hypertension
AstraZeneca 80
Load More Results